Market Cap
$81.3B
MRSH
MARSH & MCLENNAN COMPANIES, INC.
$171.85 ▲ +0.66%
Prev close $170.73Market cap$81.3B
ConsensusSell
12-mo target$205.57 (+19.6%)
▲ Neutral
Analyst conviction 4/10
Insider Selling Cluster (2 insiders)31 New Institutional Positions19 Institutional ExitsCongressional Activity (1) Traditional Finance
Snapshot
The big-picture read on MRSH right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Hold (39%)
Inst. Holders
50 funds
Inst. Value
$55.3B
Inst. Activity
31 buys / 19 sells
Insider Activity
$0.00 buy / $10.9M sell
Insider Net $
-$10.9M
SEC Reports
10
Congressional
4 trades
Price chart 30d -8.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 7, 2026 dark_pool
Sep 4, 2026 SEC Dark Pool: MRSH — 2.2M shares, 52,699 trades
Week starting 2026-09-07. Total ATS volume: 2,205,211 shares across 52,699 trades.
CEO and General Counsel of Marsh & McLennan executed same-day option exercises and open-market sales on September 2, 202
CLUSTER — Impact 2/10
Sep 2, 2026 Insider
Brennan Katherine acquired via exercise 1,197 shares
SVP and General Counsel @ $83.05 ($99.4K)
Sep 2, 2026 Insider
Brennan Katherine sold 1,197 shares
SVP and General Counsel @ $187.90 ($224.9K)
Sep 2, 2026 Insider
Doyle John Q acquired via exercise 16,656 shares
President and CEO @ $73.20 ($1.2M)
Aug 24, 2026 Congress
Jul 31, 2026 SEC Kevin Hern sell
$1,001 - $15,000 — House
Three MRSH insiders sold a combined $3.6M in shares over a week following Q2 earnings. At $91.4B market cap, the total r
CLUSTER — Impact 2/10
Two MRSH insiders sold a combined $3.46M in open-market transactions over a week following Q2 earnings. Director Lloyd Y
CLUSTER — Impact 2/10
Analyst ratings buy % -9.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
39% rate it Buy or better · 31 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 1, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Aug 19, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | 55% |
| Jul 27, 2026 | UBS | MAINTAIN | Buy | 55% |
| Jul 22, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jul 22, 2026 | Mizuho | MAINTAIN | Neutral | 52% |
| Jul 22, 2026 | Citigroup | DOWNGRADE | Neutral | 55% |
| Jul 13, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jul 10, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Jul 9, 2026 | Cantor Fitzgerald | MAINTAIN | Overweight | 49% |
| Jul 9, 2026 | Mizuho | MAINTAIN | Neutral | 52% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 9 | 18 | 1 | 0 | 39% | |
| Aug 1, 2026 | 3 | 9 | 18 | 1 | 0 | 39% | |
| Jul 1, 2026 | 4 | 9 | 17 | 1 | 0 | 42% | |
| Jun 1, 2026 | 4 | 9 | 17 | 1 | 0 | 42% | |
| May 1, 2026 | 3 | 9 | 17 | 1 | 0 | 40% | |
| Apr 1, 2026 | 3 | 9 | 17 | 1 | 0 | 40% | |
| Mar 1, 2026 | 3 | 9 | 17 | 1 | 0 | 40% | |
| Feb 1, 2026 | 2 | 11 | 16 | 1 | 0 | 43% |
Price targets
Where 21 covering analysts think MRSH trades over the next 12 months.
$205.57 +19.6% upside Buy
Current$171.85 Low$179.00 Median$201.00 High$238.00 21 analysts
$179.00$238.00
Analyst rating Hold· 2.5/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
10 SEC filing reports analyzed · 0 bullish, 0 bearish, 1 mixed, 9 neutral · avg impact 3.3/10.
NEUTRALCLUSTER2/10
CEO and General Counsel of Marsh & McLennan executed same-day option exercises and open-market sales
Sep 4, 2026
NEUTRALCLUSTER2/10
Three MRSH insiders sold a combined $3.6M in shares over a week following Q2 earnings. At $91.4B mar
Jul 31, 2026
NEUTRALCLUSTER2/10
Two MRSH insiders sold a combined $3.46M in open-market transactions over a week following Q2 earnin
Jul 30, 2026
NEUTRAL1442/10
Director Lloyd M. Yates filed a Form 144 notice to sell 12,000 shares of Marsh & McLennan common sto
Jul 23, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 7, 2026
dark_pool
Dark Pool: MRSH — 2.2M shares, 52,699 trades
Week starting 2026-09-07. Total ATS volume: 2,205,211 shares across 52,699 trades.
Aug 31, 2026
dark_pool
Dark Pool: MRSH — 2.5M shares, 60,961 trades
Week starting 2026-08-31. Total ATS volume: 2,505,670 shares across 60,961 trades.
Aug 24, 2026
dark_pool
Dark Pool: MRSH — 2.6M shares, 61,541 trades
Week starting 2026-08-24. Total ATS volume: 2,606,553 shares across 61,541 trades.
Aug 17, 2026
dark_pool
Dark Pool: MRSH — 2.3M shares, 55,587 trades
Week starting 2026-08-17. Total ATS volume: 2,302,934 shares across 55,587 trades.
Aug 10, 2026
dark_pool
Dark Pool: MRSH — 1.9M shares, 52,257 trades
Week starting 2026-08-10. Total ATS volume: 1,939,848 shares across 52,257 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $1.97 | $1.92–$2.01 | 6.6% | -0.1% | 2↑ 3↓ | $6.6B | 22 |
| Next Q | $2.23 | $2.13–$2.29 | 5.1% | -0.0% | 2↑ 3↓ | $6.9B | 21 |
| Current FY | $10.45 | $10.30–$10.54 | 7.2% | -0.0% | 4↑ 2↓ | $28.6B | 23 |
| Next FY | $11.42 | $10.90–$11.73 | 9.3% | +0.1% | 4↑ 2↓ | $30.0B | 23 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $1.971 | — |
| 7d ago | $1.974 | -0.003 |
| 30d ago | $1.974 | -0.003 |
| 60d ago | $1.977 | -0.005 |
| 90d ago | $1.985 | -0.013 |
Institutional ownership
Which big funds own MRSH (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $55.3B total value (331,954,591 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 31 institutions added/increased vs 19 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 39,502,046 | $6.6B | 11.9% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 31,472,575 | $5.2B | 9.5% | — |
| STATE STREET CORP | 22,401,676 | $3.7B | 6.7% | — |
| Capital World Investors | 18,122,340 | $3.0B | 5.5% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 16,975,238 | $2.8B | 5.1% | — |
| Capital International Investors | 15,729,457 | $2.6B | 4.7% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 13,510,274 | $2.3B | 4.1% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 12,570,512 | $2.1B | 3.8% | — |
| Capital Research Global Investors | 10,973,649 | $1.8B | 3.3% | — |
| HARRIS ASSOCIATES L P | 8,687,496 | $1.4B | 2.6% | ADD +68.1% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| HARRIS ASSOCIATES L P | ADD | 5,169,119 | 8,687,496 | +68.1% | $1.4B |
| Artisan Partners Limited Partnership | ADD | 4,875,857 | 7,269,246 | +49.1% | $1.2B |
| FMR LLC | TRIM | 10,180,705 | 6,954,123 | -31.7% | $1.2B |
| NORGES BANK | NEW | — | 6,255,525 | — | $1.0B |
| Clearbridge Investments, LLC | TRIM | 6,423,531 | 4,705,966 | -26.7% | $784.3M |
| EdgePoint Investment Group Inc. | NEW | — | 3,820,196 | — | $636.7M |
| BANK OF AMERICA CORP /DE/ | TRIM | 4,939,614 | 3,455,003 | -30.1% | $575.8M |
| Amundi | ADD | 2,298,833 | 2,884,376 | +25.5% | $480.7M |
| PRIMECAP MANAGEMENT CO/CA/ | DOUBLED | 717,500 | 2,145,025 | +199.0% | $357.5M |
| Mawer Investment Management Ltd. | TRIM | 3,475,590 | 1,871,159 | -46.2% | $311.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
19 insiders, 50 transactions. Net -$10.9M — $0.00 bought, $10.9M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Brennan Katherine | SVP and General Counsel | EXERCISE | 1,197 | $83.05 | $99.4K |
| Sep 2, 2026 | Brennan Katherine | SVP and General Counsel | SELL | 1,197 | $187.90 | $224.9K |
| Sep 2, 2026 | Doyle John Q | President and CEO | EXERCISE | 16,656 | $73.20 | $1.2M |
| Sep 2, 2026 | Doyle John Q | President and CEO | SELL | 16,656 | $188.51 | $3.1M |
| Aug 15, 2026 | Lute Jane H | Director | AWARD | 144.27 | $188.45 | $27.2K |
| Aug 15, 2026 | Yates Lloyd M | Director | AWARD | 223.73 | $188.45 | $42.2K |
| Aug 15, 2026 | BROUSSARD BRUCE D | Director | AWARD | 192 | $188.45 | $36.2K |
| Aug 15, 2026 | MILLS STEVEN A | Director | AWARD | 194 | $188.45 | $36.6K |
| Aug 15, 2026 | SCHAPIRO MORTON O | Director | AWARD | 218.9 | $188.45 | $41.3K |
| Aug 14, 2026 | Yates Lloyd M | Director | J | 64.85 | $189.15 | $12.3K |
Congressional trades
MRSH trades disclosed by members of Congress, with disclosure delay.
3 members · 2 buys / 2 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Kevin Hern | R | HOUSE | SELL | $1,001 - $15,000 | Marsh & McLennan Companies Inc | Sep 2, 2026(10d) |
| Jun 2, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Marsh & McLennan Companies Inc | Jul 8, 2026(37d) |
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Marsh & McLennan Companies Inc | May 13, 2026(31d) |
| Jan 27, 2026 | Christine Smith | D | SENATE | SELL | $50,001 - $100,000 | Marsh & McLennan Companies Inc | Jan 30, 2026(4d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for MRSH.
Shares short
5,868,686
Settlement Sep 15, 2026
Change vs prior
-11.4%
Semi-monthly cycle
Days to cover
2.8
At avg daily volume
Of shares outstanding
≈1.2%
Estimate — not % of float
All MRSH filing & press-release reports (10)
- CLUSTER reportSep 4, 2026
- CLUSTER reportJul 31, 2026
- CLUSTER reportJul 30, 2026
- 144 reportJul 23, 2026
- 8-K reportJul 21, 2026
- 8-K reportApr 16, 2026
- 8-K reportApr 14, 2026
- CLUSTER reportMar 12, 2026
- CLUSTER reportMar 5, 2026
- 8-K reportFeb 25, 2026